戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ission in the efficacy of SSRI treatment for premenstrual dysphoric disorder.
2 in reuptake inhibitors (SSRIs) in women with premenstrual dysphoric disorder.
3 fective for severe premenstrual syndrome and premenstrual dysphoric disorder.
4 ction may be involved in the pathogenesis of premenstrual dysphoric disorder.
5 rual cycle, such as acne, endometriosis, and premenstrual dysphoric disorder.
6 disorders, such as postpartum depression and premenstrual dysphoric disorder.
7 ical link between subtypes of depressive and premenstrual dysphoric disorders.
8 acebo-controlled protocol to nine women with premenstrual dysphoric disorder and 11 healthy female vo
9 a GABA levels were measured in 27 women with premenstrual dysphoric disorder and 21 comparison women
10                                   Women with premenstrual dysphoric disorder and a past history of ma
11 ssociations were particularly pronounced for premenstrual dysphoric disorder and for PMDs with sympto
12 order, 21 with major depression, and 10 with premenstrual dysphoric disorder and in 34 normal compari
13 roup of experts to examine the literature on premenstrual dysphoric disorder and provide recommendati
14 equested participation, 243 met criteria for premenstrual dysphoric disorder and were randomized; 200
15  depression, anxiety, postpartum depression, premenstrual dysphoric disorder, and schizophrenia and (
16 nic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, and social phobia.
17 tal ill health, including menstruation (with premenstrual dysphoric disorder appearing for the first
18                                              Premenstrual dysphoric disorder appears to be associated
19 tients with panic disorder and patients with premenstrual dysphoric disorder are highly susceptible t
20                                In women with premenstrual dysphoric disorder but no past major depres
21 the hypothesis of serotonergic deficiency in premenstrual dysphoric disorder by measuring the prolact
22                            The patients with premenstrual dysphoric disorder experienced a return of
23 pared to the normal subjects, the women with premenstrual dysphoric disorder had a significantly blun
24  (PMDs), including premenstrual syndrome and premenstrual dysphoric disorder, have symptom onset duri
25 e whether efficacy for premenstrual syndrome/premenstrual dysphoric disorder is a general or more ser
26                                              Premenstrual dysphoric disorder is an important cause of
27                                              Premenstrual dysphoric disorder is often associated with
28 e disorder and a state-dependent decrease in premenstrual dysphoric disorder might imply a possible c
29                                              Premenstrual dysphoric disorder (PMDD) affects over 5% o
30 id metabolite allopregnanolone in women with premenstrual dysphoric disorder (PMDD) and in asymptomat
31 strual cycle in healthy women and those with premenstrual dysphoric disorder (PMDD) and that a menstr
32         Despite evidence for the validity of premenstrual dysphoric disorder (PMDD) and the inclusion
33                                              Premenstrual dysphoric disorder (PMDD) disrupts the live
34 ymptoms repeatedly experienced by women with Premenstrual Dysphoric Disorder (PMDD) during the late l
35        There is substantial information that premenstrual dysphoric disorder (PMDD) is a clinically s
36                                              Premenstrual dysphoric disorder (PMDD) is a common mood
37                                              Premenstrual Dysphoric Disorder (PMDD) is characterized
38                                              Premenstrual dysphoric disorder (PMDD) is characterized
39 other psychiatric illnesses tested, although premenstrual dysphoric disorder (PMDD) may be an excepti
40 ors previously demonstrated that symptoms of premenstrual dysphoric disorder (PMDD) remit during ovar
41                                              Premenstrual dysphoric disorder (PMDD) symptoms are elim
42 bitors (SRIs) are efficacious treatments for premenstrual dysphoric disorder (PMDD) when given daily
43 uggests that mood and behavioral symptoms in premenstrual dysphoric disorder (PMDD), a common, recent
44 ), including premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), are associated w
45 ; most of these women also meet criteria for premenstrual dysphoric disorder (PMDD).
46 h catamenial epilepsy and enhance anxiety in premenstrual dysphoric disorder (PMDD).
47 of multiple psychiatric disorders, including premenstrual dysphoric disorder (PMDD).
48 ontext of underrecognized conditions such as Premenstrual Dysphoric Disorder (PMDD).
49 rual cycle are distinguishable in women with premenstrual dysphoric disorder (PMDD).
50 ents with major depression and patients with premenstrual dysphoric disorder, respectively).
51 relation to the menstrual cycle, as in DSM-5 premenstrual dysphoric disorder, symptom changes of simi
52             The panic rate for patients with premenstrual dysphoric disorder was similar to that for
53                                              Premenstrual dysphoric disorder, which affects 2%-5% of
54                                Patients with premenstrual dysphoric disorder (whose symptoms had remi
55 thors sought to determine whether women with premenstrual dysphoric disorder with or without prior ma